Legal Representation
Attorney
STEVEN H. HARTMAN
USPTO Deadlines
Application History
25 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 13, 2006 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Dec 13, 2006 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Apr 4, 2006 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 4, 2006 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Apr 4, 2006 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Oct 7, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 7, 2005 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Oct 7, 2005 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Apr 6, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 6, 2005 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Apr 6, 2005 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jan 24, 2005 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Dec 19, 2004 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Dec 6, 2004 | I | PAPER RECEIVED | Loading... | |
| Oct 8, 2004 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 1, 2004 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 1, 2004 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Apr 8, 2004 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 5, 2004 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 5, 2004 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 7, 2003 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 15, 2003 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 25, 2003 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| May 22, 2003 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 19, 2003 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of disorders of the central nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in ophthalmology
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005